Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
MUC16
REST API REST API
Homo sapiens
MUC16 is differentially expressed in 127 experiments: 73 organism parts: trachea, blood, ... (71 more);, 72 disease states: normal, lung adenocarcinoma, ... (70 more);, 37 cell types 287 cell lines 13 compound treatments and 57 other conditions.
Synonyms FLJ14303, CA125
Orthologs MUC1 (Saccharomyces cerevisiae)   1810055G02Rik (Mus musculus)   Sgs3 (Drosophila melanogaster)   (Compare orthologs)
InterPro Term SEA
UniProt Accession B5ME49, F8WE81
Search EB-eye ENSG00000181143
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-MEXP-1251, ... (17 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-18005, E-GEOD-29119, E-GEOD-2450, E-GEOD-19480, ... (20 experiments)

Factor Value U/D Experiments
BT474
2
 E-MEXP-440, E-MTAB-62
SKBR3
2
 E-MEXP-440, E-MTAB-62
HMCB
1
 E-MTAB-37
KHOS240S
1
 E-MTAB-37
PC3
1
 E-MEXP-2034
COLO201
1
 E-MTAB-37
281 more value(s).


Cell type

studied in E-AFMX-5, E-GEOD-18811, E-MTAB-24, E-GEOD-29119, E-GEOD-20033, ... (17 experiments)

Factor Value U/D Experiments
plasma cell
1
 E-GEOD-6691
n/a
1
 E-MTAB-24
bronchial epithelial
1
 E-AFMX-5
adult native RPE from 76 y.o. donor
1
 E-GEOD-18811
Embryonic Kidney cell
1
 E-GEOD-20677
mononuclear
1
 E-GEOD-13987
31 more value(s).


Disease state

studied in E-GEOD-5390, E-GEOD-3307, E-GEOD-19743, E-GEOD-6872, E-MEXP-2069, ... (20 experiments)

Factor Value U/D Experiments
lung adenocarcinoma
3
 E-MTAB-62, E-MTAB-37, E-GEOD-4127
cervical carcinoma
2
 E-MTAB-37, E-MTAB-62
amyotophic lateral sclerosis
1
 E-GEOD-3307
dermatomyositis
1
 E-GEOD-5370
neuroblastoma-poorly differentiated
1
 E-MTAB-62
acute quadriplegic myopathy
1
 E-GEOD-3307
66 more value(s).


Compound treatment

studied in E-MEXP-1269, E-GEOD-3284, E-GEOD-5824, E-GEOD-5099, E-GEOD-6462, ... (8 experiments)

Factor Value U/D Experiments
5-aza-2'-deoxycytidine + trichostatin A
1
1
 E-MEXP-1269
bacterial endotoxin
1
1
 E-GEOD-3284
glucose
1
 E-MEXP-941
none
1
 E-GEOD-5824
estradiol
3
1
 E-GEOD-20081
heregulin
1
 E-GEOD-6462
7 more value(s).


BioSourceProvider

studied in E-GEOD-19519, E-GEOD-19480

Factor Value U/D Experiments
Coriell: GM14478
1
 E-GEOD-19519
Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=NA19127
1
1
 E-GEOD-19480
Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=NA19159
1
1
 E-GEOD-19480


Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-TABM-234, E-GEOD-7967, E-TABM-125, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-MEXP-1251, E-GEOD-19246, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-MEXP-2359, E-GEOD-6236, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-3325, E-GEOD-22541, E-GEOD-1561, E-GEOD-21138

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MEXP-2340

Genotype
studied in E-TABM-601, E-GEOD-17347

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-TABM-127, E-MEXP-1103

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234

Individual
studied in E-GEOD-1432, E-MEXP-2069, E-GEOD-19519, E-GEOD-6919, E-GEOD-10433, ... (18 experiments)

Infection
studied in E-GEOD-12254

Injury
studied in E-GEOD-19743

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-17636

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Progression free survival of days
studied in E-GEOD-5851

Protocol type
studied in E-GEOD-1343

Qrt pcr ereg dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-10797

RNAi
studied in E-MEXP-101, E-MEXP-548, E-GEOD-3697

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-7307

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments 00 005
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-3494, E-GEOD-1561, E-GEOD-4922

Processing time: 0.589 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM